Merck & Company Inc. (MRK)

Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.58X Cap: $273.69B
- View MRK Profile
- View Questions on MRK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $504.22)
- $504.22 P/E (TTM): 66.61X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $469.90)
- $469.90 P/E (TTM): 32.86X Cap: $119.22B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.74X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.58X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $172.43)
- $172.43 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $670.46)
- $670.46 P/E (TTM): 53.17X Cap: $53.53B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $100.07)
- $100.07 P/E (TTM): 17.11X Cap: $19.64B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.13X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.99)
- $28.99 P/E (TTM): 373.55X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Gilead Sciences Inc. (GILD $141.95)
- $141.95 P/E (TTM): 21.97X Cap: $176.11B
- View GILD Profile
- View Questions on GILD
Abbott Laboratories (ABT $109.30)
- $109.30 P/E (TTM): 13.71X Cap: $190.05B
- View ABT Profile
- View Questions on ABT
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.58X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $26.44)
- $26.44 P/E (TTM): 15.37X Cap: $150.33B
- View PFE Profile
- View Questions on PFE

Q: Would you recommend starting a new position now in these big pharma stocks with rotation out of the tech sector lately? All three have decent PE, PEG and PS ratios and have been fared well in last few bear markets overall. What would your recommended allocation be across the three stocks for an investment of time line of 5 years?
Thanks!

Read Answer Asked by Scott on December 17, 2025

Garmin Ltd. (Switzerland) (GRMN $201.64)
- $201.64 P/E (TTM): 24.86X Cap: $38.78B
- View GRMN Profile
- View Questions on GRMN
AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Eaton Corporation PLC (ETN $351.42)
- $351.42 P/E (TTM): 35.14X Cap: $136.49B
- View ETN Profile
- View Questions on ETN
Kroger Company (The) (KR $62.85)
- $62.85 P/E (TTM): 20.27X Cap: $39.77B
- View KR Profile
- View Questions on KR
Altria Group Inc. (MO $61.99)
- $61.99 P/E (TTM): 11.83X Cap: $104.06B
- View MO Profile
- View Questions on MO
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.58X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
Procter & Gamble Company (The) (PG $151.77)
- $151.77 P/E (TTM): 22.16X Cap: $352.71B
- View PG Profile
- View Questions on PG
Quanta Services Inc. (PWR $474.63)
- $474.63 P/E (TTM): 70.32X Cap: $70.77B
- View PWR Profile
- View Questions on PWR
Walmart Inc. (WMT $119.14)
- $119.14 Cap: $949.56B
- View WMT Profile
- View Questions on WMT
Hilton Worldwide Holdings Inc. (HLT $298.51)
- $298.51 P/E (TTM): 43.26X Cap: $68.84B
- View HLT Profile
- View Questions on HLT
Uber Technologies Inc. (UBER $80.05)
- $80.05 P/E (TTM): 10.29X Cap: $166.33B
- View UBER Profile
- View Questions on UBER
RTX Corporation (RTX $200.93)
- $200.93 P/E (TTM): 41.26X Cap: $269.40B
- View RTX Profile
- View Questions on RTX

Q: Hi Peter, according to Analytics I need more core US Growth and Dividend stocks in the RRSP & LIRA accounts, so could you please provide me with 4 stocks for each of the following sectors:- Industrials, Discretionary, Staples and Healthcare.
Thanks Peter & 5i for your great service.
Ivan

Read Answer Asked by Ivan on December 08, 2025